Find revenue you're currently missing.
The Opportunity Atlas is a continuously updated map of where US care delivery is failing in ways CMS and payers already pay to fix — now paired with the new Demand Signals Engine that turns compliant, non-claims signals into ready-to-run marketing campaigns. Anticipate where utilization is rising or breaking down before competitors do, and size the addressable opportunity by cohort, geography, and reimbursement code. Built for BD, growth, marketing, and product leaders in medical device, digital health, HIT, and the agencies that serve hospitals and health systems.
Watch how we turn reimbursed demand into a prioritized backlog.
Your team is chasing markets, not opportunities.
Most BD teams pursue named accounts and broad TAM estimates. Meanwhile, specific, reimbursable problems sit unaddressed in public CMS data — waiting for a product like yours. The Opportunity Atlas finds them, ranks them, and ties each one to a path through existing payment.
Utilization is always shifting — services rising in one region, declining in another, new procedures concentrating in specific cohorts. Most teams notice the shift quarters after it shows up in claims. The Opportunity Atlas surfaces the change while it's still actionable — early enough to recruit, staff, bid, build, or sell into it.
Seven opportunities your sales team could be pitching this quarter.
Each one is something CMS or a payer is already paying to solve. The Opportunity Atlas shows you which markets, which buyers, and how to frame the ask.
Use these as templates. The Opportunity Atlas produces a custom set for your product, segment, and geography.
Sleep Apnea: Therapy Fulfillment Gap
Markets where diagnostic sleep test volume (HCPCS 95810) is high, but therapy fulfillment (CPAP HCPCS E0601) lags by 30%+.
MA plans lose triple-weighted Star points on care coordination when diagnosed patients are never started on therapy.
“Stop losing patients at diagnosis. We have identified the 12 counties where your DME network is missing 40% of the therapy volume you have already paid to diagnose.”
DME Suppliers · Sleep Clinic MSOs · MA Plan Operations
COPD: Hospital-to-Home Shift
States with top-quartile Inpatient spend but bottom-decile Home Oxygen utilization (HCPCS E1392).
CMS penalizes 30-day COPD readmissions. Home oxygen and pulmonary rehab prevent ER visits at a fraction of admission cost.
“Recover your MA Star points and cut avoidable admissions — funded by home oxygen workflows you are already eligible to bill.”
Health System VPs of Value-Based Care · ACO Quality Officers
Heart Failure: RPM Revenue Transition
High economic density (spend per patient) but near-zero utilization of Remote Physiological Monitoring (RPM) codes.
Transitions of care are high-risk. RPM creates a continuous care bridge that protects BPCI-A bundle savings.
“Turn your Heart Failure discharge program into a paid workflow. Less than 2% of eligible CHF beneficiaries in high-spend counties are enrolled in a digital bridge.”
Cardiology Groups · MSOs · Post-Acute Care Leaders
Type 2 Diabetes: Silent Nephropathy Screen
High volume of E&M visits (99213/99214) but low utilization of critical kidney screening labs.
Dialysis is the single largest cost driver for MA plans. Early detection of kidney disease in diabetic cohorts saves millions in long-term claims.
“Your diabetic population has a 40% screening gap in high-density regions. Close it now to save $12k per patient in avoided dialysis costs.”
MA Quality Leaders · Primary Care Network Managers
Parkinson’s: Neurology Access Optimisation
Geographic hotspots where Parkinson’s prevalence is high, but the primary specialty managing care is Internal Medicine rather than Neurology.
Specialist-led care reduces fall-related fractures and expensive Skilled Nursing Facility (SNF) stays.
“Your Parkinson’s members are being managed by GPs without specialised protocols. We found where a Neurologist partnership yields the highest ROI.”
Neurological MSOs · Payer Network Strategy Leads
Hypertriglyceridaemia: Metabolic Market Density
States where allowed spend per patient is more than 2x the national average for metabolic conditions.
Managing high-cost metabolic tiers reduces long-term cardiovascular event spend, a primary driver of Medical Loss Ratios (MLR).
“Optimise your metabolic sales force. Here are the 10 states where spend-per-patient indicates a premium specialty clinical service opportunity.”
Specialty Pharma BD · Metabolic Centre Developers
Regional Intensity: GPCI Bonus Finder
Markets with high beneficiary volume and a Geographic Practice Cost Index (GPCI) above 1.1.
Higher GPCI means Medicare pays more for the same CPT code. These are high-yield markets where every intervention generates 10-15% more gross revenue.
“Do not just target by volume — target by yield. We have mapped the high-reimbursement clusters where your clinical services generate 15% more revenue.”
Healthcare Private Equity · Multi-State Provider Groups
A working revenue engine. Not another dashboard.
Opportunity briefs
Strategy memos tied to specific cohorts, geographies, and reimbursement paths.
See the flow →Reimbursement-aligned targets
Every opportunity mapped to existing CMS, MA, or commercial payment.
See the SQL layer →Demand-signal campaigns
Compliant non-claims signals — search, environment, foot traffic — turned into ready-to-run media plans.
See the Demand Signals Engine →Patients wait weeks for slots that are partially empty — and partially mis-assigned.
Most health systems don't have a demand problem. They have a capacity allocation problem. The team closest to the booking decision is marketing — and that makes the front door a triage layer, not just an acquisition channel.
AMN/Merritt Hawkins, 2022
MGMA; BMC Health Svcs Res, 2023
Kaiser Permanente DOR; npj Digital Medicine, 2024
Spot the shift. Size the prize. Sharpen the pitch.
TAM decks age fast. The Opportunity Atlas computes your addressable market the way a BD team actually defends one — bottom-up, by cohort, by geography, by reimbursable code — and refreshes it as utilization moves.
Catch utilization changes in time to act.
See where specific procedures, prescriptions, and care patterns are climbing or collapsing — at the cohort and HRR level. Move before the trend is common knowledge.
Compute TAM, don't buy it.
Eligible population × geographic distribution × allowed spend per service line. The result is a defensible financial scope you can put in front of a board, not a vendor's slide.
Every gap becomes a value-prop bullet.
Each underserved cohort, fulfillment break, or quality miss is a pain point your buyer already feels. The brief tells you what to say, where to say it, and which buyer to say it to.
Reimbursed demand. Plus the demand that hasn't shown up in claims yet.
The Opportunity Atlas finds revenue you can already bill for. The new Demand Signals Engine finds the demand that's about to surface — in time to bid keywords, build creative, and ship campaigns.
Reimbursement-aligned revenue map.
CMS, MA, CMMI, MIPS, and HEDIS data turned into ranked opportunity briefs for BD and product teams in medical device, digital health, and HIT.
- — Cohort × geography × reimbursement code
- — SQL-native, runs in your environment
- — Sales-ready opportunity briefs
Marketing-activation companion.
30+ compliant, non-claims data sources — search intent, AQI, foot traffic, surveillance, retail proxies, employer signals — turned into ready-to-run campaigns for hospitals, health systems, physician groups, and their agencies.
- — 11 signal categories, 0–90 days ahead of claims
- — Mapped to Google, Meta, programmatic, and CRM
- — Trust earned through aggregation, not avoided through obscurity
What an Opportunity Atlas brief looks like.
Each brief is a working strategy memo: cohort, geography, signal in the data, reimbursement path, and the revenue at stake — ready for BD and product teams.
Get a brief for your product$4.2B+ national revenue potential in integrated Sleep Apnea management.
Built on public, defensible sources. Extensible with your proprietary data.
See the Opportunity Atlas against your roadmap.
30 minutes. No slides. We'll show the Opportunity Atlas running against the segment you care about.